全文获取类型
收费全文 | 3402篇 |
免费 | 249篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 130篇 |
妇产科学 | 94篇 |
基础医学 | 545篇 |
口腔科学 | 38篇 |
临床医学 | 286篇 |
内科学 | 818篇 |
皮肤病学 | 81篇 |
神经病学 | 398篇 |
特种医学 | 120篇 |
外科学 | 338篇 |
综合类 | 13篇 |
一般理论 | 1篇 |
预防医学 | 208篇 |
眼科学 | 24篇 |
药学 | 230篇 |
中国医学 | 5篇 |
肿瘤学 | 312篇 |
出版年
2024年 | 5篇 |
2023年 | 44篇 |
2022年 | 111篇 |
2021年 | 146篇 |
2020年 | 102篇 |
2019年 | 124篇 |
2018年 | 112篇 |
2017年 | 98篇 |
2016年 | 110篇 |
2015年 | 125篇 |
2014年 | 172篇 |
2013年 | 195篇 |
2012年 | 307篇 |
2011年 | 309篇 |
2010年 | 155篇 |
2009年 | 147篇 |
2008年 | 264篇 |
2007年 | 209篇 |
2006年 | 178篇 |
2005年 | 188篇 |
2004年 | 138篇 |
2003年 | 119篇 |
2002年 | 88篇 |
2001年 | 19篇 |
2000年 | 21篇 |
1999年 | 21篇 |
1998年 | 19篇 |
1997年 | 17篇 |
1996年 | 23篇 |
1995年 | 9篇 |
1994年 | 6篇 |
1993年 | 9篇 |
1992年 | 10篇 |
1991年 | 8篇 |
1990年 | 4篇 |
1989年 | 3篇 |
1988年 | 11篇 |
1986年 | 10篇 |
1985年 | 5篇 |
1984年 | 8篇 |
1983年 | 1篇 |
1980年 | 3篇 |
1979年 | 1篇 |
1975年 | 1篇 |
1974年 | 2篇 |
1972年 | 1篇 |
1971年 | 2篇 |
1970年 | 2篇 |
1967年 | 1篇 |
1966年 | 2篇 |
排序方式: 共有3666条查询结果,搜索用时 15 毫秒
141.
142.
143.
144.
Amalia Conti Virginia Espina Antonella Chiechi Giovanna Magagnoli Chiara Novello Laura Pazzaglia Irene Quattrini Piero Picci Lance A. Liotta Maria Serena Benassi 《Clinical & experimental metastasis》2014,31(1):15-24
We applied reverse phase protein microarrays technology to map signal pathway interactions in a discovery set of 34 soft tissue sarcoma (STS) bone metastases compared to healthy bone. Proteins associated with matrix remodeling (MMP), adhesion (FAK Y576/577, Syndecan-1), and growth/survival (IGF1R Y1135/1136, PI3K, EGFR) were elevated in metastasis compared to normal bone. Linkage between Syndecan-1, FAK Y576/577, Shc Y317, and EGFR, IGF Y1135/1136, PI3K/AKT was a prominent feature of STS bone metastasis. Elevated linkage between RANKL and 4EBP1 T37/46, EGFR, IGF1R Y1135/1136, Src Y41, Shc Y317, PI3Kp110γ was associated with short survival. Finally, we tested the hypothesis that signal pathway proteins augmented in the STS bone metastasis may provide clues to understand the subset of primary STS that metastasize. The most representative molecules identified in the discovery set were validated on an independent series of 82 primary STS by immunohistochemistry applied to a tissue microarray. The goal was to correlate the molecular profile in the primary tumors with a higher likelihood of metastasis. Elevation of activated kinase substrate endpoints IRS1 S612, 4EBP1 T37/46, FAK Y576/577 and loss of Fibronectin, were associated with a higher likelihood of metastases. These data indicate that the linkage between matrix remodeling, adhesion, and growth signaling may drive STS metastasis and can be the basis for prognostic and therapeutic strategies. 相似文献
145.
146.
Vittoria D'Esposito Manuela Lecce Gaetano Marenzi Serena Cabaro Maria Rosaria Ambrosio Gilberto Sammartino Saverio Misso Teresa Migliaccio Pasquale Liguoro Francesco Oriente Leonzio Fortunato Francesco Beguinot Jos Camilla Sammartino Pietro Formisano Roberta Gasparro 《Journal of tissue engineering and regenerative medicine》2020,14(5):701-713
Diabetic patients display increased risk of periodontitis and failure in bone augmentation procedures. Mesenchymal stem cells (MSCs) and platelet‐rich plasma (PRP) represent a relevant advantage in tissue repair process and regenerative medicine. We isolated MSCs from Bichat's buccal fat pad (BFP) and measured the effects of glucose and PRP on cell number and osteogenic differentiation potential. Cells were cultured in the presence of 5.5‐mM glucose (low glucose [LG]) or 25‐mM glucose (high glucose [HG]). BFP–MSC number was significantly lower when cells were cultured in HG compared with those in LG. Following osteogenic differentiation procedures, calcium accumulation, alkaline phosphatase activity, and expression of osteogenic markers were significantly lower in HG compared with LG. Exposure of BFP–MSC to PRP significantly increased cell number and osteogenic differentiation potential, reaching comparable levels in LG and in HG. Thus, high‐glucose concentrations impair BFP–MSC growth and osteogenic differentiation. However, these detrimental effects are largely counteracted by PRP. 相似文献
147.
Sara Canovas Nunes Serena De Vita Andrew Anighoro Franois Autelitano Edward Beaumont Pamela Klingbeil Meaghan McGuinness Beatrice Duvert Chad Harris Lu Yang Sheela Pangeni Pokharel Chun-Wei Chen Monika Ermann David A. Williams Haiming Xu 《Blood cancer journal》2022,12(4)
RAS mutations prevalent in high-risk leukemia have been linked to relapse and chemotherapy resistance. Efforts to directly target RAS proteins have been largely unsuccessful. However, since RAS-mediated transformation is dependent on signaling through the RAS-related C3 botulinum toxin substrate (RAC) small GTPase, we hypothesized that targeting RAC may be an effective therapeutic approach in RAS mutated tumors. Here we describe multiple small molecules capable of inhibiting RAC activation in acute lymphoblastic leukemia cell lines. One of these, DW0254, also demonstrates promising anti-leukemic activity in RAS-mutated cells. Using chemical proteomics and biophysical methods, we identified the hydrophobic pocket of phosphodiester 6 subunit delta (PDE6D), a known RAS chaperone, as a target for this compound. Inhibition of RAS localization to the plasma membrane upon DW0254 treatment is associated with RAC inhibition through a phosphatidylinositol-3-kinase/AKT-dependent mechanism. Our findings provide new insights into the importance of PDE6D-mediated transport for RAS-dependent RAC activation and leukemic cell survival.Subject terms: Acute lymphocytic leukaemia, Acute myeloid leukaemia, Drug development, Targeted therapies 相似文献
148.
149.
150.
Bruna Neroni Maria Antonella Zingaropoli Giulia Radocchia Maria Rosa Ciardi Luciana Mosca Fabrizio Pantanella Serena Schippa 《Oncology Letters》2022,23(4)
Violacein is a natural pigment, a pyrrolidone, and a bisindole derived from the condensation of two tryptophan molecules, which gives a blue violet color to several gram-negative violacein-producing bacteria. Violacein production provides a competitive advantage against antagonistic species or predators. In addition, the compound has antibacterial, antifungal, antiviral, and antioxidant activities. Several studies on colon, breast, and head and neck cancer lines have already demonstrated the anti-proliferative potential of violacein. Bladder cancer is one of the most common types of cancer in urology. The therapeutic approach is mainly based on surgery, chemotherapy, and immunotherapy. The aim of the present study was to evaluate the anti-proliferative activity of violacein against the human bladder cancer cell lines, HTB4 (T24) and HTB9 (5637), using low-grade and high-grade transitional cell carcinoma models, respectively, which has never been assayed before. For this purpose, the potential violacein anti-proliferative effect on T24 and 5637 cells was evaluated by studying the cell viability, proliferation, cell cycle, and caspase-3 activation. The results showed that violacein had anti-proliferative activity in the two cell lines, which was greater for the second-stage bladder cancer cell line (5637), and a different mode of action against the two cell lines. 相似文献